Contemporary practices of blood glucose management in diabetic patients: a survey of hyperbaric medicine units in Australia and New Zealand
Diving and Hyperbaric Medicine Journal · 2023
DOI: 10.28920/dhm53.3.230-236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diving and Hyperbaric Medicine Journal, 2023. Verfasst von Brenda R Laupland und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hyperbaric Medicine Unit, Royal Brisbane and Women's Hospital, Brisbane, Australia. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Blood glucose levels may be influenced by hyperbaric oxygen treatment (HBOT). Patients with diabetes mellitus commonly receive HBOT but there is a lack of standardised blood glucose management guidelines. We documented relevant contemporary practices applied for patients with diabetes treated in hyperbaric medicine units.
Methods
A survey was administered in 2022 to the directors of all 13 accredited hyperbaric units in Australia and New Zealand to identify policies and practices related to management of patients with diabetes receiving HBOT.
Results
Twelve of the 13 units routinely managed patients with diabetes. Three-quarters (9/12) used < 4 mmol·l-1 as their definition of hypoglycaemia, whereas the other three used < 5, < 3.6, and < 3 mmol·l-1. Units reported 26% (range 13–66%) of their patients have a diagnosis of diabetes of which 93% are type 2. Ten (83%) units reported specific written protocols for managing blood glucose. Protocols were more likely to be followed by nursing (73%) than medical staff (45%). Ten (83%) units routinely tested blood glucose levels on all patients with diabetes. Preferred pre-treatment values for treatments in both multiplace and monoplace chambers ranged from ≥ 4 to ≥ 8 mmol·l-1. Seven (58%) units reported continuation of routine testing throughout a treatment course with five (42%) units having criteria-based rules for discontinuing testing for stable patients over multiple treatments. Two-thirds of units were satisfied with their current policy.
Conclusions
This survey highlights the burden of diabetes on patients treated with HBOT and identifies considerable variability in practices which may benefit from further study to optimise management of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hyperbaric Medicine Unit, Royal Brisbane and Women's Hospital, Brisbane, Australia.
- Corresponding author: Dr Brenda Laupland, Hyperbaric Medicine Unit, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, 4029 Australia, ORCiD ID: 0009-0005-4883-1932, kbetlaup@gmail.com.
- Queensland University of Technology (QUT), Brisbane, Australia.
- Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.
- Clinical Informatics, Digital Metro North, Metro North Health, Brisbane, Australia.
Zitieren
APA
Laupland, B. R., Laupland, K., Thistlethwaite, K., & Webb, R. (2023). Contemporary practices of blood glucose management in diabetic patients: a survey of hyperbaric medicine units in Australia and New Zealand. Diving and Hyperbaric Medicine Journal. https://doi.org/10.28920/dhm53.3.230-236
Vancouver
Laupland BR, Laupland K, Thistlethwaite K, Webb R. Contemporary practices of blood glucose management in diabetic patients: a survey of hyperbaric medicine units in Australia and New Zealand. Diving and Hyperbaric Medicine Journal. 2023. doi:10.28920/dhm53.3.230-236
BibTeX
@article{Laupland2023,
author = {Laupland, Brenda R and Laupland, Kevin and Thistlethwaite, Kenneth and Webb, Robert},
title = {Contemporary practices of blood glucose management in diabetic patients: a survey of hyperbaric medicine units in Australia and New Zealand},
journal = {Diving and Hyperbaric Medicine Journal},
year = {2023},
doi = {10.28920/dhm53.3.230-236}
}
EUVIMED